CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

SingHealth

Sean Lam, PhD, Head of Data Science

Data Science And Artificial Intelligence In Healthcare

Sean Lam

Sean Lam

Given the need for deep human touch, health systems around the world can function effectively only with well-trained health workers. The World Health Organization has projected a shortfall of 18 million health workers by 2030. Singapore is facing a similar scenario of healthcare workforce shortfalls, exacerbated by a fast-aging population. In order to future-proof and ensure the continued accessibility, quality, and affordability of healthcare, the Singapore government has made three key shifts to movebeyondthe hospital to the community, beyond quality to value, and beyond healthcare to health. In order to achieve this goal, data science and AI technologiescan play a key enabling role to alleviate the increasing burden in our healthcare systems.


Beyond looking at the piecemeal application of new technologies, health systems would have to evolve into dynamic learning systems open to the effective adoption of these technologies. The learning healthcare system has been defined as a system where science, informatics, incentives, and culture are aligned withbest practices derived through continuous improvement and innovation embedded seamlessly in the care delivery process, with new knowledge captured to establish a lean learning loop. The ability to capture, analyze, and synthesize data for high priority and impactful health service delivery and clinical use casesis an important precursor to the development of efficacious evidence-based interventions. To achieve this, data science and AI have generated much interest in many health systems around the world. The healthcare and biomedical industries are where these technologies would be expected to play a game-changing role in their transformation.


The ability to capture, analyze, and synthesize data for high priority and impactful health service delivery and clinical use cases is an important precursor to the development of efficacious evidence-based interventions.


AI goes beyond traditional machine learning(with deep learning as a subfield) and analytics. AI also encompasses the fields of decision science, optimization, expert systems, and intelligent autonomous agents, amongst others. In order to reap optimal gains in the rapidly evolving field of AI, there is a need to bring down silos in the traditional academic, medicine, and health services disciplines. In fact, from the perspective of moving beyond healthcare to health, with individuals at the centre of the healthcare enterprise, the primary care, specialty care, long-term care, public health, and community healthcare resources would all have to work closely in a synergistic manner, taking into account the individual’s socioeconomic environment. To achieve this, the effective utilization and flow of data and information is key.


We did not just come to realize the power and importance of data science and AI in healthcare. The field has undergone cycles of boom and bust over the years. Successes and failures in the ability to deliver through such technologies hold important learning lessons for the continuous development and implementation of AI technologies for healthcare. As an example,  thinking in AI governance has started to embrace the importance of fairness and explain ability. Transparency, accountability, and ethical considerations are all important considerations in responsible AI.Investments in data, privacy, and AI governance have driven the rapid evolution of data science and AI technologies towards a more utopic and sustainable trajectory.


For technologies to work well in healthcare delivery, they have to be seamlessly embedded as best practices within the service delivery process. To achieve this, implementation and improvement sciences can play important roles in interweaving new innovations into day-to-day service delivery operations. The rigorous evidence-based paradigm behind implementation science, coupled with rapid improvement cycles built upon the field of improvement science for continuous quality improvements, will enable a virtuous cycle of building trust and establishing traction and momentum for efficient yet rigorous evidence-based adoption cycles.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://drug-discovery-and-development-apac.lifesciencesreview.com/leadership-perspective/data-science-and-artificial-intelligence-in-healthcare--nwid-756.html